3494 employees
Biocon is a fully integrated pure play biosimilars organization, globally engaged in developing high quality affordable biosimilars.
1978
$76M
from 1 investors over 1 rounds
Biocon Biologics raised $76M on January 7, 2021
Investors: ADQ